Clin-e-cal uses its patented Sound Response technology to develop apps to provide real-time feedback to inhaler users & facilitate remote disease management. With thousands of downloads, they're on a mission to help the world’s 500m asthma & COPD sufferers. Raising to commercialise & scale-up activities.
Clin-e-cal started with our founder, Tariq Aslam, solving problems he had giving inhaler medication to his young son - Rafi. He realised his wasn’t a unique problem and Rafi-Tone, the solution he developed, had the potential to help many children using inhalers with a spacer. Since launching in 2016, the app, powered by our patented Sound Response engine, has had thousands of downloads across the UK, Australia, and Scandinavia.
We are now planning to advance the sound analysis technology to address problems in inhaler users of all ages. Currently undergoing beta testing, the first version of our new Clip-Tone Buddy app uses sound analysis to give real-time feedback, helping patients understand how to use their inhalers correctly. We have estimated a £300m near-term addressable opportunity and we are targeting pharma companies and inhaler manufacturers directly to build the user base and develop real-world insights.
We believe these insights can help transform care, providing healthcare professionals with detailed information on patients’ inhaler use. We strive for our data to ultimately help streamline clinical trials, identify patients most at risk and impact future respiratory device design.
We are raising now to progress commercialisation of the Clip-Tone Buddy, scale the sales activity and for additional support in marketing, regulatory and legal aspects of the business.